The colorant is in the form of concentrate pellets added to the polymer pellets during the extrusion and melting process. It was a natural and obvious choice to collaborate with Avient as a global leader in sustainable color and material solutions. Sustainable infrastructure solutions that increase energy efficiency, renewable energy, natural resource conservation and fiber optic / 5G network accessibility    

Nymax™ Polymer Formulations Design Guide Nymax™ BIO Bio-based Polyamide Solutions Injection molding parameters and guidelines for Nymax BIO Bio-based Polyamide Solutions.

NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, today held its 2016 annual meeting of shareholders, during which time all presented proposals before shareholders were approved. is a premier provider of specialized polymer materials, services and solutions. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to realize anticipated savings and operational benefits from the realignment of assets, including the closure of manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen loss of customers and/or disruptions of service or quality caused by such closings and/or production shifts; separation and severance amounts that differ from original estimates; amounts for non-cash charges related to asset write-offs and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired businesses into our operations, including whether such businesses will be accretive to our earnings, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.

CLEVELAND - PolyOne Corporation (NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced that its Board of Directors has appointed Robert M. About PolyOne PolyOne Corporation, with 2013 revenues of $3.8 billion, is a premier provider of specialized polymer materials, services and solutions. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the inability to achieve expected results from our acquisition activities; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.

Avient healthcare solutions, qualifications and USP Class VI Colors Automotive Solutions Brochure - Industry Overview Automotive Solutions - Colorants, Additives, Advanced Composites, Engineered Polymers, Elastomers, Vinyl, Polyolefins

Pultruded composites are a type of high-performance, fiber-reinforced polymer (FRP) composite material that are manufactured using a continuous process called pultrusion. Medical: brace stiffeners and endoscopic dissectors rods.

Pultruded composites are a type of high-performance, fiber-reinforced polymer (FRP) composite material that are manufactured using a continuous process called pultrusion. Medical: brace stiffeners and endoscopic dissectors rods.

Pultruded composites are a type of high-performance, fiber-reinforced polymer (FRP) composite material that are manufactured using a continuous process called pultrusion. Medical: brace stiffeners and endoscopic dissectors rods.

Solutions include radiopacity, acid acceptors, viscosity modifiers, mold releases, and more. Silicone Formulations Leverage customization opportunities for fully formulated silicone solutions that shorten development cycles and streamline operations for medical equipment components. Scan this code or click here to learn more about our healthcare solutions.

Mevopur™ Healthcare Functional Additives Laser Marking Additives for Medical Devices and Pharmaceutical Packaging Laser marking offers several advantages compared to other marking technologies. Potential applications include graduation markings for dose-dials, syringes and droppers, and serialization/coding (e.g., UDI) for medical devices and pharmaceutical packaging. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.